The latest research report released by Polaris Market Research titled Neuromodulation Market Opportunity offers a thorough assessment of a rapidly growing market. It covers all the major market aspects, including market share, size, trends, and major market developments. In addition, a thorough assessment of the key market opportunities, market restraints, and challenges has been provided. The research report has been prepared by expert researchers and experienced analysts who have vast experience in the market.
The report sheds light on major market players, market segments, and geographic landscape. Also, an assessment of the cost structure, and product landscape and price has been included in the study. The research report makes use of quantitative and qualitative analysis, along with graphical representations such as charts, tables, and graphs, to provide a comprehensive market analysis. The report is a must-have for businesses, investors, and stakeholders looking to develop effective operating strategies in the Neuromodulation market.
Market Stats
According to the research report, the global neuromodulation market was valued at USD 5.61 billion and is expected to reach USD 14.57 billion by 2030, to grow at a CAGR of 11.9% during the forecast period.
Market Dynamics
Market Drivers
The study shares crucial information on various market factors, including growth drivers, financial data, and development patterns. In addition, information on innovations and the latest technologies has been included. The Neuromodulation market report has been prepared by considering the market’s evolving nature. It sheds light on demand and supply trends and the major factors contributing to the products/services demand in the market. A thorough assessment of major market trends and opportunities has been provided in the report.
Market Restraints
The research report identifies risks, challenges, and threats that may impede the market growth in the coming years. Knowing these market restraints is crucial as it informs stakeholders about the potential market barriers. By going through the information, businesses can effectively address these issues and capitalize on emerging market opportunities. In addition, the information will enable stakeholders to make more informed decisions.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/neuromodulation-market
Some of the top market players are:
- LivaNova PLC
- Medtronic
- Electrocore Inc.
- Boston Scientific Corporation
- Abbott
- Inspire Medical Systems Inc.
- Neuronetics
- ReShape Lifesciences Inc.
- NeuroPace
Regional Analysis
The research report discusses the Neuromodulation market growth across various regions and sub-regions. The regional analysis has been done by analyzing the market at the national, regional, and global levels by various market segments. Also, an assessment of the market’s historical performance in specific regions and their logisitics, supply and demand, and production capacity has been provided. The study also includes forecast analysis covering important information about revenue projection, global production, and regional forecasts.
A few of the key regions and sub-regions covered in the market research report are:
• North America (US, Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Argentina, and Rest of Latin America)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of Middle East & Africa)
Recent Developments
-
February 2022: Medtronic (Ireland) received FDA approval for its InterStim X System, an advanced sacral nerve stimulation therapy designed for personalized bladder and bowel control treatment.
-
June 2021: NeuroSigma (US) and KT Corporation (South Korea) signed a memorandum of agreement for a strategic collaboration to develop and market electronic treatments for neurological and neuropsychological disorders, including ADHD, depression, and epilepsy.
-
February 2020: LivaNova Plc (UK) and Verily (US), an Alphabet company, established a research partnership to integrate depression measurement into the RECOVER clinical trial. This study evaluates the effectiveness of vagus nerve stimulation (VNS) therapy for treatment-resistant depression (DTD).
-
January 2020: Medtronic Plc (Ireland) acquired Stimgenics, LLC, a privately held US company, to enhance its portfolio of spinal cord stimulation products.
-
November 2018: electroCore Inc., a commercial-stage medical device company, received FDA approval for gammaCore, a non-invasive vagus nerve stimulation (nVNS) device. In the US, the device is approved as an adjunctive therapy for treating cluster headaches.
-
October 2017: The US FDA approved SenTiva, a vagus nerve stimulation (VNS) device by LivaNova PLC, for managing epilepsy. The device is indicated for patients aged four and older with drug-resistant epilepsy.
Segmental Overview
This report section divides the market into various groups tied together by similarities. By going through the Neuromodulation market segmentation section, businesses can devise effective strategies tailored to each of these market groups. In addition, stakeholders can align their objectives and market channels with high precision. Segmental analysis can help stakeholders focus their resources on the most promising market segments. Businesses can gain a better understanding of shifting market trends and apply data-driven go-to-market strategies. What’s more, businesses can develop services, products, or new features that will cater to every segment.
The Report Answers Questions Such As
• What are the major changes in Neuromodulation market dynamics and competitive landscape in recent years?
• What are the challenges and restraining factors of the market?
• Which region accounted for the largest market share in the market?
• Which segment is projected to witness the fastest growth during the forecast period?
• What are the emerging trends market participants can capitalize on?
• How can businesses create effective sales and marketing strategies?
More Trending Latest Reports By Polaris Market Research:
Software-defined Anything (SDx) Market
